精功科技(002006.SZ):收到國興碳纖維支付的碳化線裝置購銷合同進度款7909.49萬元
格隆匯5月13日丨精功科技(002006.SZ)公佈,2022年5月13日,公司收到國興碳纖維支付的編號為RC2109290885的《碳化線裝置購銷合同》進度款79,094,902.23元。
截至公吿披露日,公司累計收到國興碳纖維支付的預付款及進度款312,105,883.38元,其中,編號為RC2109290885的《碳化線裝置購銷合同》收到預付款及進度款222,105,883.38元,編號為RC2109290887的《碳化線裝置購銷合同》收到預付款9000萬元,合同正在履行中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.